Neurosurgery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Neurosurgery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


Global neurosurgery market is poised for significant growth over the next decade, with projections indicating a rise from US$ 5.1 billion in 2024 to US$ 7.7 billion by 2031, according to a detailed analysis by Fairfield Market Research. This anticipated growth, representing a Compound Annual Growth Rate (CAGR) of 6%, underscores the evolving landscape of neurosurgical practices, heavily influenced by technological advancements and an increasing preference for minimally invasive surgical procedures.

Technological Innovations Spearheading Market Growth

At the forefront of this market expansion are neuro-interventional devices, which captured a dominant share of 60.8% in 2022. These devices, integral to minimally invasive surgeries, are revolutionizing neurosurgery by offering solutions that reduce patient recovery time and minimize surgical complications. Major companies, including Elekta, Stryker Corp, and B. Braun Melsungen AG, are leading the charge by introducing cutting-edge devices that promise to enhance clinical outcomes and patient experiences.

Elekta's launch of the Elekta Esprit in May 2022, for instance, exemplifies the industry's shift towards innovative solutions offering faster, automated treatment planning, and superior visualization capabilities. Similarly, Stryker Corp's Surpass Evolve Flow Diverter has witnessed growing adoption across more than 50 countries, highlighting the global market's readiness for advanced neurosurgical technologies.

Addressing Market Opportunities and Challenges

While the neurosurgery market is on an upward trajectory, it faces its share of challenges, particularly concerning the high costs associated with complex neurosurgeries and the lack of comprehensive reimbursement policies. The report acknowledges these hurdles but also emphasizes the opportunities lying in ongoing technological advancements and the increasing incidence of neurological diseases, which collectively fuel the demand for neurosurgical services and products.

In the U.S., which held more than 91% of the North American market share in 2022, the demand for neurosurgical products is notably robust, driven by significant healthcare expenditure and a strong focus on R&D by leading manufacturers. Similarly, Germany and the U.K. are identified as key markets in Europe, thanks to their advanced healthcare systems, substantial investment in clinical trials, and emphasis on specialized neurosurgical training and services.

Competitive Analysis and Strategic Initiatives

The competitive landscape of the neurosurgery market is characterized by a blend of innovation, regulatory approvals, and strategic collaborations. Boston Scientific's FDA approval for its Vercise Genus Deep Brain Stimulation System in January 2022, and Medtronic plc's acquisition of Intersect ENT are prime examples of strategies employed by leading players to consolidate their market positions.

Furthermore, partnerships like the one between Elekta and IBA, aimed at optimizing quality assurance in radiation therapy, highlight the industry's commitment to enhancing the safety and efficacy of neurosurgical procedures.

Key Companies Profiled
• B. Braun Melsungen AG
• Medtronic plc
• DePuy Synthes
• Boston Scientific
• Stryker Corp.
• Terumo Corporation
• KARL STORZ GmbH & Co KG
• Integra LifeSciences
• Penumbra Inc
• Adeor Medical AG
• Elekta
• Clarus Medical
• MACHIDA ENDOSCOPE CO., LTD.

Key Segments Covered in Neurosurgery Industry Research

Neurosurgery Market by Product:
• Neuro Interventional Devices
Neurovascular Embolization Devices
Embolization Coils
Liquid Embolic Systems
Flow Diversion Stents
Aneurysm Clips
Neurovascular Coiling Assist Devices
Coiling Assist Stents
Coiling Assist Balloons
Neurovascular Thrombectomy Devices
Stent Retrievers
Aspiration Retrievers
Microguidewires
Microcatheters
Support Catheters
Intracranial Stents
• Neuroendoscopes
Flexible Neuroendoscopes
Rigid Neuroendoscopes
• Neurosurgical Drills
Pneumatic Neurosurgical Drills
Electrical Neurosurgical Drills
• Radiosurgery Systems
Linear Accelerator Radiosurgery Systems
GammaKnife Radiosurgery Systems
• Dura Substitutes
Biological Dura Substitutes
Synthetic Dura Substitutes
• Neurosurgical Ablation Devices
MRI Guided Focused Ultrasound Systems
MRI Guided Laser Therapy Systems
MRI Guided RF Ablation Systems
• Neurosurgery Instruments
Tissue Retractors
Forceps
Head Frames
Cervical Plating systems
Perforators

Neurosurgery Market by End User:
• Hospitals
• Ambulatory Surgical Centers
• Specialized Neurological Institutes

Neurosurgery Market by Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Neurosurgery Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Neurosurgery Market Outlook, 2018 – 2031
3.1. Global Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Neuro Interventional Devices
3.1.1.1.1. Neurovascular Embolization Devices
3.1.1.1.1.1. Embolization Coils
3.1.1.1.1.2. Liquid Embolic Systems
3.1.1.1.1.3. Flow Diversion Stents
3.1.1.1.1.4. Aneurysm Clips
3.1.1.1.2. Neurovascular Coiling Assist Devices
3.1.1.1.2.1. Coiling Assist Stents
3.1.1.1.2.2. Coiling Assist Balloons
3.1.1.1.3. Neurovascular Thrombectomy Devices
3.1.1.1.3.1. Stent Retrievers
3.1.1.1.3.2. Aspiration Retrievers
3.1.1.1.4. Microguidewires
3.1.1.1.5. Microcatheters
3.1.1.1.6. Support Catheters
3.1.1.1.7. Intracranial Stents
3.1.1.2. Neuroendoscopes
3.1.1.2.1. Flexible Neuroendoscopes
3.1.1.2.2. Rigid Neuroendoscopes
3.1.1.3. Neurosurgical Drills
3.1.1.3.1. Pneumatic Neurosurgical Drills
3.1.1.3.2. Electrical Neurosurgical Drills
3.1.1.4. Radiosurgery Systems
3.1.1.4.1. Linear Accelerator Radiosurgery Systems
3.1.1.4.2. GammaKnife Radiosurgery Systems
3.1.1.5. Dura Substitutes
3.1.1.5.1. Biological Dura Substitutes
3.1.1.5.2. Synthetic Dura Substitutes
3.1.1.6. Neurosurgical Ablation Devices
3.1.1.6.1. MRI Guided Focused Ultrasound Systems
3.1.1.6.2. MRI Guided Laser Therapy Systems
3.1.1.6.3. MRI Guided RF Ablation Systems
3.1.1.7. Neurosurgery Instruments
3.1.1.7.1. Tissue Retractors
3.1.1.7.2. Forceps
3.1.1.7.3. Head Frames
3.1.1.7.4. Cervical Plating systems
3.1.1.7.5. Perforators
3.2. Global Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Ambulatory Surgical Centres
3.2.1.3. Specialized Neurological Institutes
3.3. Global Neurosurgery Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Neurosurgery Market Outlook, 2018 – 2031
4.1. North America Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Neuro Interventional Devices
4.1.1.1.1. Neurovascular Embolization Devices
4.1.1.1.1.1. Embolization Coils
4.1.1.1.1.2. Liquid Embolic Systems
4.1.1.1.1.3. Flow Diversion Stents
4.1.1.1.1.4. Aneurysm Clips
4.1.1.1.2. Neurovascular Coiling Assist Devices
4.1.1.1.2.1. Coiling Assist Stents
4.1.1.1.2.2. Coiling Assist Balloons
4.1.1.1.3. Neurovascular Thrombectomy Devices
4.1.1.1.3.1. Stent Retrievers
4.1.1.1.3.2. Aspiration Retrievers
4.1.1.1.4. Microguidewires
4.1.1.1.5. Microcatheters
4.1.1.1.6. Support Catheters
4.1.1.1.7. Intracranial Stents
4.1.1.2. Neuroendoscopes
4.1.1.2.1. Flexible Neuroendoscopes
4.1.1.2.2. Rigid Neuroendoscopes
4.1.1.3. Neurosurgical Drills
4.1.1.3.1. Pneumatic Neurosurgical Drills
4.1.1.3.2. Electrical Neurosurgical Drills
4.1.1.4. Radiosurgery Systems
4.1.1.4.1. Linear Accelerator Radiosurgery Systems
4.1.1.4.2. GammaKnife Radiosurgery Systems
4.1.1.5. Dura Substitutes
4.1.1.5.1. Biological Dura Substitutes
4.1.1.5.2. Synthetic Dura Substitutes
4.1.1.6. Neurosurgical Ablation Devices
4.1.1.6.1. MRI Guided Focused Ultrasound Systems
4.1.1.6.2. MRI Guided Laser Therapy Systems
4.1.1.6.3. MRI Guided RF Ablation Systems
4.1.1.7. Neurosurgery Instruments
4.1.1.7.1. Tissue Retractors
4.1.1.7.2. Forceps
4.1.1.7.3. Head Frames
4.1.1.7.4. Cervical Plating systems
4.1.1.7.5. Perforators
4.2. North America Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Ambulatory Surgical Centres
4.2.1.3. Specialized Neurological Institutes
4.3. North America Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
4.3.1.2. U.S. Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
4.3.1.3. Canada Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
4.3.1.4. Canada Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurosurgery Market Outlook, 2018 – 2031
5.1. Europe Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Neuro Interventional Devices
5.1.1.1.1. Neurovascular Embolization Devices
5.1.1.1.1.1. Embolization Coils
5.1.1.1.1.2. Liquid Embolic Systems
5.1.1.1.1.3. Flow Diversion Stents
5.1.1.1.1.4. Aneurysm Clips
5.1.1.1.2. Neurovascular Coiling Assist Devices
5.1.1.1.2.1. Coiling Assist Stents
5.1.1.1.2.2. Coiling Assist Balloons
5.1.1.1.3. Neurovascular Thrombectomy Devices
5.1.1.1.3.1. Stent Retrievers
5.1.1.1.3.2. Aspiration Retrievers
5.1.1.1.4. Microguidewires
5.1.1.1.5. Microcatheters
5.1.1.1.6. Support Catheters
5.1.1.1.7. Intracranial Stents
5.1.1.2. Neuroendoscopes
5.1.1.2.1. Flexible Neuroendoscopes
5.1.1.2.2. Rigid Neuroendoscopes
5.1.1.3. Neurosurgical Drills
5.1.1.3.1. Pneumatic Neurosurgical Drills
5.1.1.3.2. Electrical Neurosurgical Drills
5.1.1.4. Radiosurgery Systems
5.1.1.4.1. Linear Accelerator Radiosurgery Systems
5.1.1.4.2. GammaKnife Radiosurgery Systems
5.1.1.5. Dura Substitutes
5.1.1.5.1. Biological Dura Substitutes
5.1.1.5.2. Synthetic Dura Substitutes
5.1.1.6. Neurosurgical Ablation Devices
5.1.1.6.1. MRI Guided Focused Ultrasound Systems
5.1.1.6.2. MRI Guided Laser Therapy Systems
5.1.1.6.3. MRI Guided RF Ablation Systems
5.1.1.7. Neurosurgery Instruments
5.1.1.7.1. Tissue Retractors
5.1.1.7.2. Forceps
5.1.1.7.3. Head Frames
5.1.1.7.4. Cervical Plating systems
5.1.1.7.5. Perforators
5.2. Europe Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Ambulatory Surgical Centres
5.2.1.3. Specialized Neurological Institutes
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Germany Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
5.3.1.2. Germany Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
5.3.1.4. U.K. Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
5.3.1.5. France Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
5.3.1.6. France Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
5.3.1.7. Italy Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
5.3.1.8. Italy Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
5.3.1.9. Turkey Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
5.3.1.10. Turkey Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
5.3.1.12. Russia Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
5.3.1.13. Rest of Europe Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurosurgery Market Outlook, 2018 – 2031
6.1. Asia Pacific Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Neuro Interventional Devices
6.1.1.1.1. Neurovascular Embolization Devices
6.1.1.1.1.1. Embolization Coils
6.1.1.1.1.2. Liquid Embolic Systems
6.1.1.1.1.3. Flow Diversion Stents
6.1.1.1.1.4. Aneurysm Clips
6.1.1.1.2. Neurovascular Coiling Assist Devices
6.1.1.1.2.1. Coiling Assist Stents
6.1.1.1.2.2. Coiling Assist Balloons
6.1.1.1.3. Neurovascular Thrombectomy Devices
6.1.1.1.3.1. Stent Retrievers
6.1.1.1.3.2. Aspiration Retrievers
6.1.1.1.4. Microguidewires
6.1.1.1.5. Microcatheters
6.1.1.1.6. Support Catheters
6.1.1.1.7. Intracranial Stents
6.1.1.2. Neuroendoscopes
6.1.1.2.1. Flexible Neuroendoscopes
6.1.1.2.2. Rigid Neuroendoscopes
6.1.1.3. Neurosurgical Drills
6.1.1.3.1. Pneumatic Neurosurgical Drills
6.1.1.3.2. Electrical Neurosurgical Drills
6.1.1.4. Radiosurgery Systems
6.1.1.4.1. Linear Accelerator Radiosurgery Systems
6.1.1.4.2. GammaKnife Radiosurgery Systems
6.1.1.5. Dura Substitutes
6.1.1.5.1. Biological Dura Substitutes
6.1.1.5.2. Synthetic Dura Substitutes
6.1.1.6. Neurosurgical Ablation Devices
6.1.1.6.1. MRI Guided Focused Ultrasound Systems
6.1.1.6.2. MRI Guided Laser Therapy Systems
6.1.1.6.3. MRI Guided RF Ablation Systems
6.1.1.7. Neurosurgery Instruments
6.1.1.7.1. Tissue Retractors
6.1.1.7.2. Forceps
6.1.1.7.3. Head Frames
6.1.1.7.4. Cervical Plating systems
6.1.1.7.5. Perforators
6.2. Asia Pacific Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Ambulatory Surgical Centres
6.2.1.3. Specialized Neurological Institutes
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
6.3.1.2. China Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
6.3.1.3. Japan Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
6.3.1.4. Japan Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
6.3.1.5. South Korea Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
6.3.1.8. India Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
6.3.1.9. Southeast Asia Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
6.3.1.11. Rest of Asia Pacific Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
6.3.1.12. Rest of Asia Pacific Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurosurgery Market Outlook, 2018 – 2031
7.1. Latin America Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Neuro Interventional Devices
7.1.1.1.1. Neurovascular Embolization Devices
7.1.1.1.1.1. Embolization Coils
7.1.1.1.1.2. Liquid Embolic Systems
7.1.1.1.1.3. Flow Diversion Stents
7.1.1.1.1.4. Aneurysm Clips
7.1.1.1.2. Neurovascular Coiling Assist Devices
7.1.1.1.2.1. Coiling Assist Stents
7.1.1.1.2.2. Coiling Assist Balloons
7.1.1.1.3. Neurovascular Thrombectomy Devices
7.1.1.1.3.1. Stent Retrievers
7.1.1.1.3.2. Aspiration Retrievers
7.1.1.1.4. Microguidewires
7.1.1.1.5. Microcatheters
7.1.1.1.6. Support Catheters
7.1.1.1.7. Intracranial Stents
7.1.1.2. Neuroendoscopes
7.1.1.2.1. Flexible Neuroendoscopes
7.1.1.2.2. Rigid Neuroendoscopes
7.1.1.3. Neurosurgical Drills
7.1.1.3.1. Pneumatic Neurosurgical Drills
7.1.1.3.2. Electrical Neurosurgical Drills
7.1.1.4. Radiosurgery Systems
7.1.1.4.1. Linear Accelerator Radiosurgery Systems
7.1.1.4.2. GammaKnife Radiosurgery Systems
7.1.1.5. Dura Substitutes
7.1.1.5.1. Biological Dura Substitutes
7.1.1.5.2. Synthetic Dura Substitutes
7.1.1.6. Neurosurgical Ablation Devices
7.1.1.6.1. MRI Guided Focused Ultrasound Systems
7.1.1.6.2. MRI Guided Laser Therapy Systems
7.1.1.6.3. MRI Guided RF Ablation Systems
7.1.1.7. Neurosurgery Instruments
7.1.1.7.1. Tissue Retractors
7.1.1.7.2. Forceps
7.1.1.7.3. Head Frames
7.1.1.7.4. Cervical Plating systems
7.1.1.7.5. Perforators
7.2. Latin America Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Ambulatory Surgical Centres
7.2.1.3. Specialized Neurological Institutes
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
7.3.1.2. Brazil Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
7.3.1.3. Mexico Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
7.3.1.4. Mexico Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
7.3.1.5. Argentina Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
7.3.1.8. Rest of Latin America Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurosurgery Market Outlook, 2018 – 2031
8.1. Middle East & Africa Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Neuro Interventional Devices
8.1.1.1.1. Neurovascular Embolization Devices
8.1.1.1.1.1. Embolization Coils
8.1.1.1.1.2. Liquid Embolic Systems
8.1.1.1.1.3. Flow Diversion Stents
8.1.1.1.1.4. Aneurysm Clips
8.1.1.1.2. Neurovascular Coiling Assist Devices
8.1.1.1.2.1. Coiling Assist Stents
8.1.1.1.2.2. Coiling Assist Balloons
8.1.1.1.3. Neurovascular Thrombectomy Devices
8.1.1.1.3.1. Stent Retrievers
8.1.1.1.3.2. Aspiration Retrievers
8.1.1.1.4. Microguidewires
8.1.1.1.5. Microcatheters
8.1.1.1.6. Support Catheters
8.1.1.1.7. Intracranial Stents
8.1.1.2. Neuroendoscopes
8.1.1.2.1. Flexible Neuroendoscopes
8.1.1.2.2. Rigid Neuroendoscopes
8.1.1.3. Neurosurgical Drills
8.1.1.3.1. Pneumatic Neurosurgical Drills
8.1.1.3.2. Electrical Neurosurgical Drills
8.1.1.4. Radiosurgery Systems
8.1.1.4.1. Linear Accelerator Radiosurgery Systems
8.1.1.4.2. GammaKnife Radiosurgery Systems
8.1.1.5. Dura Substitutes
8.1.1.5.1. Biological Dura Substitutes
8.1.1.5.2. Synthetic Dura Substitutes
8.1.1.6. Neurosurgical Ablation Devices
8.1.1.6.1. MRI Guided Focused Ultrasound Systems
8.1.1.6.2. MRI Guided Laser Therapy Systems
8.1.1.6.3. MRI Guided RF Ablation Systems
8.1.1.7. Neurosurgery Instruments
8.1.1.7.1. Tissue Retractors
8.1.1.7.2. Forceps
8.1.1.7.3. Head Frames
8.1.1.7.4. Cervical Plating systems
8.1.1.7.5. Perforators
8.2. Middle East & Africa Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Ambulatory Surgical Centres
8.2.1.3. Specialized Neurological Institutes
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. GCC Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
8.3.1.2. GCC Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
8.3.1.3. South Africa Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
8.3.1.6. Egypt Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
8.3.1.7. Nigeria Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
8.3.1.8. Nigeria Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
8.3.1.9. Rest of Middle East & Africa Neurosurgery Market by Product, Value (US$ Bn), 2018 – 2031
8.3.1.10. Rest of Middle East & Africa Neurosurgery Market by End User, Value (US$ Bn), 2018 – 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. B. Braun Melsungen AG
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Medtronic plc
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. DePuy Synthes
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Boston Scientific
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Stryker Corp.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Terumo Corporation
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. KARL STORZ GmbH & Co KG
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Integra LifeSciences
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Penumbra Inc
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Adeor Medical AG
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Elekta
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology 10.2.Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings